Emmaus Life Sciences, Inc. Financial Ratios — EMMA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-2,919.05	-1,375.65	-1,428.14	-194.49	-355.13	-1,100.98	-215.27	-170.68	-169.77	2.28	-27.43	-20.25	-8.95	-21.96	-33.27
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-32.05	-14.78	-8.94	45.97	95.1	93.54	58.37	37.1	95.19	90.3	83.93	85.93	95.47	92.79	93.12
EBITDA Margin (%)	-4,739.05	-4,162.7	-3,199.08	-2,817.54	-2,639.56	-4,417.86	-5,490.19	-769.82	-19.51	0.12	-29.45	-35.52	12.07	-11.24	2.17
Operating Margin (%)	-4,749.73	-4,179.04	-3,209.01	-2,825.17	-2,647.15	-4,426.32	-5,528.09	-778.78	-19.83	-0.14	-29.73	-35.81	11.96	-11.37	1.85
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.35	- -	-50.6
Pretax Margin (%)	-7,474.96	-2,534.26	-8,317.19	-1,965.14	-3,371.03	-6,978.73	-5,533.23	-785.34	-240.32	4.2	-77.25	-57.45	-12.81	-38.58	-60.09
Profit Margin (%)	-7,959.25	-2,962.43	-8,332.62	-1,970.98	-3,376.02	-6,981.08	-5,535.25	-729.66	-241.04	5.84	-77.37	-57.78	-12.61	-38.75	-60.16
Net Income to Common Margin (%)	-7,959.25	-2,962.43	-8,332.62	-1,970.98	-3,376.02	-6,981.08	-5,535.25	-729.66	-241.04	5.84	-77.37	-57.78	-12.61	-38.75	-60.16
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	7	- -	1	3	- -	- -	1	19	19	22	31	33	33	33
ST Debt	- -	7	- -	- -	- -	- -	- -	- -	16	12	14	25	29	30	29
LT Debt	- -	- -	- -	1	3	- -	- -	1	4	7	8	6	4	3	4
Total Debt/EBITDA	- -	-1.55	- -	-0.39	-1.05	-0.02	-0.01	-0.06	-4.39	678.36	-3.69	-4.72	9.36	-17.61	120.59
Net Debt/EBITDA	0.01	-1.54	0.3	-0.06	-0.88	0.06	0.77	0.26	-2.88	424.79	-2.66	-3.91	7.67	-15.14	106.2
Total Debt/EBIT	- -	-1.54	- -	-0.39	-1.04	-0.02	-0.01	-0.06	-4.32	-593.56	-3.66	-4.68	9.44	-17.4	140.95
Net Debt/EBIT	0.01	-1.54	0.3	-0.06	-0.88	0.06	0.76	0.26	-2.83	-371.69	-2.63	-3.88	7.74	-14.96	124.13
EBITDA to Interest Expense	-0.7	-1.16	-3.25	- -	-10.26	-1.38	-1,068.92	-117.35	-0.16	- -	-1.96	-1.3	0.48	-0.34	0.04
EBITDA-CapEx/Interest Expense	-0.7	-1.17	-3.25	- -	-10.26	-1.41	-1,088.62	-117.99	-0.16	-4.37	-1.98	-1.31	0.48	-0.34	0.04
EBIT to Interest Expense	-0.7	-1.17	-3.26	- -	-10.29	-1.38	-1,076.3	-118.71	-0.16	-0.01	-1.98	-1.31	0.48	-0.34	0.03
Interest Expense	8	4	1	- -	- -	3	- -	- -	28	6	3	5	7	5	7
Common Equity/Total Assets	-11,414.76	-36,425.7	-4,026.39	-4,424.2	-11,037.28	-13,382.52	-1,240.83	-1,654.53	-380.42	-377.97	-425.17	-523.15	-727.88	-1,112.24	-1,259.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.07	17.95	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-0.02	-0.01	-0.01	-2.57	-4.62	-0.05	- -	-0.69	-1.9	-3.32	-3.62	-2.84	-1.83	-1.33	-1.55
Long-Term Debt/Total Assets (%)	2.76	3.99	0.43	110.64	487.71	7.05	0.06	11.45	6.61	11.49	13.94	13.02	11.56	12.97	17.17
Total Debt/Equity (%)	-0.14	-56.58	-0.61	-84.12	-57.24	-8.79	0.8	17.99	-176.2	-368.24	-104.47	-90.4	-69.99	-58.36	-51.19
Total Debt/Capital (%)	-0.04	-19.34	-0.02	-2.57	-4.63	-0.14	-0.05	-0.69	-9.42	-9.22	-10.24	-13.92	-15.01	-14.36	-13.71
Total Debt/Total Assets (%)	4.41	5,904.07	0.94	110.9	488.13	18.28	0.59	11.47	32.76	31.9	39.5	63.9	95.01	139.66	151.89
Net Debt to Equity	0.59	-56.48	58.63	-13.55	-48.25	21.65	-119.13	-81.15	-115.65	-230.59	-75.19	-74.92	-57.37	-50.17	-45.08
Net Debt/Capital (%)	0.16	-19.31	2.19	-0.41	-3.87	0.34	6.68	3.01	-6.13	-5.7	-7.29	-11.43	-12.17	-12.27	-11.97
EBITDA	-5	-5	-4	-4	-3	-4	-7	-10	-4	- -	-6	-7	4	-2	- -
EBITDA-CapEx	-5	-5	-4	-4	-3	-4	-7	-10	-4	-26	-6	-7	4	-2	- -
Operating Income (Loss)	-5	-5	-4	-4	-3	-4	-7	-10	-5	- -	-6	-7	4	-2	- -

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.01	- -	0.36	0.77	0.24	0.21	3.53	2.79	0.9	0.11	0.06	0.04	0.04	0.02	0.03
Current Ratio	0.03	0.01	0.38	0.81	0.3	0.26	3.68	3.01	1.26	0.48	0.25	0.12	0.19	0.11	0.11
Quick Ratio	0.01	- -	0.37	0.77	0.25	0.21	3.63	2.85	0.97	0.11	0.09	0.04	0.13	0.06	0.07
CFO/Avg Current Liab	-0.52	-0.19	-0.36	-1.26	-1.26	-1.78	-3.11	-6.67	-0.27	-0.09	-0.04	-0.11	-0.03	-0.04	- -
Common Equity/Total Assets	-11,414.76	-36,425.7	-4,026.39	-4,424.2	-11,037.28	-13,382.52	-1,240.83	-1,654.53	-380.42	-377.97	-425.17	-523.15	-727.88	-1,112.24	-1,259.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.07	17.95	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-0.02	-0.01	-0.01	-2.57	-4.62	-0.05	- -	-0.69	-1.9	-3.32	-3.62	-2.84	-1.83	-1.33	-1.55
Long-Term Debt/Total Assets (%)	2.76	3.99	0.43	110.64	487.71	7.05	0.06	11.45	6.61	11.49	13.94	13.02	11.56	12.97	17.17
Total Debt/Equity (%)	-0.14	-56.58	-0.61	-84.12	-57.24	-8.79	0.8	17.99	-176.2	-368.24	-104.47	-90.4	-69.99	-58.36	-51.19
Total Debt/Capital (%)	-0.04	-19.34	-0.02	-2.57	-4.63	-0.14	-0.05	-0.69	-9.42	-9.22	-10.24	-13.92	-15.01	-14.36	-13.71
Total Debt/Total Assets (%)	4.41	5,904.07	0.94	110.9	488.13	18.28	0.59	11.47	32.76	31.9	39.5	63.9	95.01	139.66	151.89
CFO/Total Liabilities	-35.44	-17.7	-85.23	-105.6	-39.91	-188.91	-309.43	-484.57	-6.41	-3.79	-1.6	-6.16	-1.81	-2.85	-0.01
CFO/CapEx	-193.46	-91.65	- -	- -	- -	-36.19	-36.86	-163.74	-75.38	-0.09	-17.18	-195.12	-88.41	-190.5	-11
Altman's Z-Score	-243.14	-761.16	-64.3	-67.32	-175.82	-256.56	-16.42	-38.2	-4.32	-4.59	-5.91	-8.5	-10.69	-18.02	-20.45

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	3.27	7.28	6.71	7.53	9.49	10.07	22.16	37.69	20.56	19.73	33.3	25.99	10.03	4.09	4.59
Days Sales Outstanding	111.56	50.15	54.37	48.5	38.47	36.24	16.47	9.68	17.75	18.5	10.96	14.04	36.37	89.28	79.53
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	0.27	0.3	0.58	0.76	0.66	0.72	0.54
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	1,329.71	1,222.46	632.52	477.48	556.2	508.45	679.32
Accounts Payable Turnover	0.09	0.05	0.05	0.04	0.01	0.01	0.09	1.53	2.38	0.29	0.26	0.18	0.18	0.32	0.21
Accounts Payable Turnover Days	3,876.17	6,674.11	7,141.18	8,405.25	64,094.74	42,426.27	3,968.95	239.05	153.49	1,244.32	1,402.62	2,064.31	2,006.69	1,124.36	1,723.77
Cash Conversion Cycle	-3,764.61	-6,623.96	-7,086.8	-8,356.75	-64,056.28	-42,390.03	-3,952.47	-229.37	1,193.98	-3.36	-759.13	-1,572.79	-1,414.11	-526.63	-964.92
Inventory to Cash Days	111.56	50.15	54.37	48.5	38.47	36.24	16.47	9.68	-1,311.96	-1,203.96	-621.56	-463.43	-519.83	-419.16	-599.78
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	8	7	4	2	2	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	2	1	- -	1	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	5	6	6	5	5	5	5
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	14	1	23	22	6	4	11	8	83	60	82	13	5	1	1
- Cash & Cash Equivalents	- -	- -	1	1	- -	- -	5	3	2	2	2	2	3	1	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	-1	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	7	- -	1	3	- -	- -	1	19	19	22	31	33	33	33
Enterprise Value	14	9	21	23	8	4	5	5	73	77	102	42	36	32	31
Total Capital	-42	-38	-56	-58	-60	-68	-76	-85	-207	-206	-219	-221	-223	-230	-237
Total Debt/Capital (%)	-0.04	-19.34	-0.02	-2.57	-4.63	-0.14	-0.05	-0.69	-9.42	-9.22	-10.24	-13.92	-15.01	-14.36	-13.71
Total Debt / EV	- -	0.85	- -	0.07	0.33	0.03	0.01	0.12	0.27	0.25	0.22	0.74	0.92	1.03	1.04
EV/Sales	125.28	76.08	164.09	167.21	84.36	42.61	41.41	3.66	3.21	3.31	4.97	2.26	1.22	1.93	2.51
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	2,737.51	- -	- -	10.13	- -	115.79
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.22	- -	135.34
EV/Cash Flow to Firm	4.12	4.89	- -	- -	- -	- -	- -	- -	3.15	13.03	55.29	- -	6.28	9.94	4.38
EV/Free Cash Flow to Firm	4.09	4.82	- -	- -	- -	- -	- -	- -	3.14	2.39	53.19	- -	6.26	9.9	4.38
Diluted Market Cap	14	1	23	22	6	4	11	8	83	60	82	13	5	1	1
Diluted Enterprise Value	14	9	21	23	8	4	5	5	101	77	102	42	36	32	31
EV per Share	8,963.2	5,485.29	340.05	272.91	99.53	33.9	11.33	5.56	1.73	1.57	2.08	0.84	0.68	0.51	0.49
TTM Sales	- -	- -	- -	- -	- -	- -	- -	1	23	23	21	18	30	17	12
TTM EBITDA	-5	-5	-4	-4	-3	-4	-7	-10	-4	- -	-6	-7	4	-2	- -
TTM Operating Income	-5	-5	-4	-4	-3	-4	-7	-10	-5	- -	-6	-7	4	-2	- -
TTM Cash Flow to Firm	3	2	-2	-3	-2	- -	-5	-9	23	6	2	- -	6	3	7
TTM Free Cash Flow to Firm	3	2	-2	-3	-2	- -	-5	-9	23	32	2	- -	6	3	7

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-3.37	-0.59	-7.49	-6.83	-2.83	-1.33	-2.3	-0.91	-18.65	2.54	-69.65	-2.55	-3.58	-0.24	-83.25
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.22	- -	135.34
Enterprise Value	14	9	21	23	8	4	5	5	73	77	102	42	36	32	31
Low Price	4,320	612	360	264	36	16.8	18.6	6.89	1.33	0.7	1.08	0.07	0.05	- -	0.01
EV/Sales	125.28	76.08	164.09	167.21	84.36	42.61	41.41	3.66	3.21	3.31	4.97	2.26	1.22	1.93	2.51
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	2,737.51	- -	- -	10.13	- -	115.79
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	44.42	- -	- -	- -	- -	- -
Price/Earnings Average	-2.27	-1.78	-6.4	-16.54	-4.41	-0.6	-2.68	-1.38	-4.51	50.77	-4.59	-3.03	-3.52	-0.58	-0.13
Price/Earnings High	-4.11	-4.49	-17.37	-33.57	-8.1	-1.4	-3.96	-2.74	-9.95	78	-12.35	-7.45	-8.39	-1.29	-0.4
Price/Earnings Low	-0.76	-0.29	-2.08	-8.21	-0.9	-0.3	-1.23	-0.62	-1.02	25.28	-3.34	-0.33	-0.72	- -	-0.07
Price/Book Value	-0.33	-0.03	-0.4	-0.38	-0.1	-0.06	-0.14	-0.1	-0.37	-0.27	-0.34	-0.05	-0.02	- -	- -
Price/Book Value Average	-0.48	-0.13	-1.24	-0.75	-0.24	-0.05	-0.25	-0.16	-1.09	-0.31	-0.3	-0.13	-0.05	-0.01	- -
Price/Book Value High	-0.86	-0.34	-3.36	-1.51	-0.44	-0.12	-0.37	-0.31	-2.41	-0.47	-0.82	-0.31	-0.12	-0.03	-0.01
Price/Book Value Low	-0.16	-0.02	-0.4	-0.37	-0.05	-0.03	-0.12	-0.07	-0.25	-0.15	-0.22	-0.01	-0.01	- -	- -
Price/Tangible Book Value	-1.23	-0.1	-10.53	-12.69	-1.26	-3.34	2.39	4.61	-7.53	-11.66	-3.83	-0.38	-0.11	-0.01	-0.01
Price/Tangible Book Value Average	-1.76	-0.46	-32.32	-25	-3.08	-3.09	4.25	7.43	-22.37	-13.33	-3.41	-0.94	-0.28	-0.07	-0.02
Price/Tangible Book Value High	-3.19	-1.17	-87.73	-50.75	-5.65	-7.25	6.28	14.73	-49.35	-20.48	-9.18	-2.32	-0.66	-0.15	-0.05
Price/Tangible Book Value Low	-0.59	-0.07	-10.53	-12.4	-0.63	-1.56	1.95	3.35	-5.09	-6.64	-2.48	-0.1	-0.06	- -	-0.01
Price/Sales	125.79	11.82	173.72	165.42	61.03	45.25	83.54	6.25	3.66	2.6	3.99	0.7	0.18	0.03	0.07
Price/Sales Average	180.46	52.73	533.25	325.97	149.03	41.75	148.54	10.07	10.87	2.97	3.55	1.75	0.44	0.22	0.08
Price/Sales High	327.05	133.15	1,447.65	661.69	273.6	98.05	219.25	19.96	23.97	4.56	9.56	4.3	1.06	0.5	0.24
Price/Sales Low	60.38	8.49	173.72	161.75	30.51	21.12	67.97	4.54	2.47	1.48	2.58	0.19	0.09	- -	0.04
Price/Cash Flow	-3.35	-0.58	-7.49	-6.83	-2.83	-1.29	-2.24	-0.91	-18.41	-24.54	-65.59	-2.53	-3.54	-0.24	-75.68
Price/Cash Flow Average	-4.81	-2.59	-22.99	-13.46	-6.92	-1.19	-3.98	-1.46	-54.66	-28.04	-58.41	-6.34	-8.75	-1.63	-88.35
Price/Cash Flow High	-8.72	-6.55	-62.41	-27.33	-12.7	-2.8	-5.88	-2.9	-120.6	-43.09	-157.11	-15.59	-20.85	-3.66	-273.62
Price/Cash Flow Low	-1.61	-0.42	-7.49	-6.68	-1.42	-0.6	-1.82	-0.66	-12.43	-13.97	-42.42	-0.69	-1.79	- -	-46.57
Price/Free Cash Flow Average	-4.84	-2.62	-22.99	-13.46	-6.92	-1.23	-4.09	-1.47	-55.39	2.9	-62.02	-6.38	-8.85	-1.64	-97.18
Price/Free Cash Flow High	-8.76	-6.62	-62.41	-27.33	-12.7	-2.88	-6.04	-2.92	-122.22	4.45	-166.82	-15.67	-21.08	-3.67	-300.98
Price/Free Cash Flow Low	-1.62	-0.42	-7.49	-6.68	-1.42	-0.62	-1.87	-0.67	-12.59	1.44	-45.04	-0.69	-1.81	- -	-51.23
EV/Sales Average	179.95	116.99	523.62	327.76	172.37	39.11	106.42	7.48	11.64	3.68	4.53	3.32	1.49	2.12	2.52
EV/Sales High	326.54	197.41	1,438.03	663.47	296.94	95.41	177.13	17.37	24.75	5.27	10.54	5.87	2.1	2.4	2.69
EV/Sales Low	59.86	72.75	164.09	163.53	53.85	18.48	25.85	1.96	3.25	2.19	3.56	1.76	1.13	1.9	2.48
EV/EBITDA Average	-3.8	-2.81	-16.37	-11.63	-6.53	-0.89	-1.94	-0.97	-59.68	3,044.44	-15.39	-9.33	12.32	-18.85	116.31
EV/EBITDA High	-6.89	-4.74	-44.95	-23.55	-11.25	-2.16	-3.23	-2.26	-126.87	4,361.59	-35.78	-16.52	17.42	-21.33	123.86
EV/EBITDA Low	-1.26	-1.75	-5.13	-5.8	-2.04	-0.42	-0.47	-0.25	-16.65	1,812.14	-12.08	-4.94	9.4	-16.87	114.61
EV/EBIT Average	-3.79	-2.8	-16.32	-11.6	-6.51	-0.88	-1.93	-0.96	-58.71	-2,663.88	-15.24	-9.26	12.44	-18.64	135.95
EV/EBIT High	-6.87	-4.72	-44.81	-23.48	-11.22	-2.16	-3.2	-2.23	-124.81	-3,816.39	-35.43	-16.38	17.57	-21.08	144.77
EV/EBIT Low	-1.26	-1.74	-5.11	-5.79	-2.03	-0.42	-0.47	-0.25	-16.38	-1,585.62	-11.97	-4.9	9.48	-16.67	133.96
Last Price	9,000	852	360	270	72	36	22.86	9.48	1.97	1.23	1.67	0.26	0.1	0.01	0.01
High Price	23,400	9,600	3,000	1,080	322.8	78	60	30.29	12.91	2.16	4	1.6	0.59	0.13	0.05
Enterprise Value Average	20	13	69	44	17	3	14	10	265	85	93	61	44	35	31
Enterprise Value High	36	23	188	90	30	8	23	23	563	122	217	108	62	40	33
Enterprise Value Low	7	8	21	22	5	2	3	3	74	51	73	32	34	32	31

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	1	1	48	49	49	50	62	64	70
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	42	49	49	49	53	63	64
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	42	49	49	49	53	63	64
Revenue per Share	71.55	72.1	2.07	1.63	1.18	0.8	0.27	1.52	0.54	0.47	0.42	0.37	0.56	0.26	0.19
EBITDA per Share	-3,390.69	-3,001.32	-66.3	-45.99	-31.14	-35.14	-15.02	-11.69	-0.11	- -	-0.12	-0.13	0.07	-0.03	- -
Operating Income per Share	-3,398.33	-3,013.1	-66.5	-46.11	-31.23	-35.21	-15.13	-11.82	-0.11	- -	-0.12	-0.13	0.07	-0.03	- -
Basic EPS, GAAP	-5,694.67	-2,135.92	-172.68	-32.17	-39.83	-55.54	-15.15	-11.08	-1.3	0.03	-0.32	-0.21	-0.07	-0.1	-0.12
Basic EPS from Cont Ops	-5,349	-1,828.4	-172.37	-32.14	-39.83	-55.54	-15.15	-11.92	-1.3	0.03	-0.32	-0.21	-0.07	-0.1	-0.12
Diluted EPS, GAAP	-5,694.67	-2,135.92	-172.68	-32.17	-39.83	-55.54	-15.15	-11.08	-1.3	0.03	-0.32	-0.21	-0.07	-0.1	-0.12
Diluted EPS from Cont Ops	-5,349	-1,828.4	-172.37	-32.14	-39.83	-55.54	-15.15	-11.92	-1.3	0.03	-0.32	-0.21	-0.07	-0.1	-0.12
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2,683.88	-1,465.2	-48.07	-39.52	-25.42	-27.84	-10.21	-10.43	-0.11	-0.05	-0.03	-0.1	-0.03	-0.04	- -
Free Cash Flow per Basic Share	-2,697.75	-1,481.19	-48.07	-39.52	-25.42	-28.61	-10.48	-10.49	-0.11	-0.59	-0.03	-0.1	-0.03	-0.04	- -
Cash & Equivalents per Share	47.27	4.83	20.16	14.99	5.09	2.97	11.6	3.76	0.7	0.05	0.05	0.04	0.05	0.02	0.03
Book Value per Share	-27,125.63	-28,615.3	-893.8	-714.15	-737.74	-640.64	-161.09	-98.36	-5.35	-4.6	-4.9	-5.1	-4.82	-4.15	-4.22
Tangible Book Value per Share	-7,335.58	-8,197.3	-34.2	-21.28	-57.16	-10.77	9.56	2.06	-0.26	-0.11	-0.44	-0.69	-0.9	-0.89	-0.99

Emmaus Life Sciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)